Open access peer-reviewed Edited Volume

Gestational Diabetes Mellitus - New Developments

Miroslav Radenkovic

Faculty of Medicine, University of Belgrade

Full-time professor of Pharmacology, Clinical Pharmacology, and Toxicology, former Chairman of Department of Pharmacology, Clinical Pharmacology and Toxicology at the Faculty of Medicine, University of Belgrade, and former Member of the Ethics Committee at the Faculty of Medicine, University of Belgrade.

Covering

Prevalence Risk Factors Diagnosis Metabolic Issues Epigenetic Modifications Microbiota Disturbances Pharmacotherapy Insulin Preventive Measures Fetal Development Issues Long-Term Offspring Outcomes Maternal Adverse Outcomes

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

Gestational diabetes mellitus is defined as diabetes diagnosed in the second or third trimester of pregnancy, with no evidence of pre-existing type 1 or type 2 diabetes. Although gestational diabetes mellitus normally disappears after delivery, this pathological condition may have long-term medical consequences for both mother and offspring. In accordance, increased risk of miscarriage, macrosomia, complications around delivery and stillbirth have been clearly connected with diabetes developed during pregnancy. Although much knowledge has been acquired regarding prevention, diagnosis, implications, and management of gestational diabetes mellitus, the exact mechanisms of gestational diabetes mellitus development are still under investigation. In that way, we can recognize recent efforts in deeper understanding of the adverse genetic background and the epigenetic modifications linked to nutritional and environmental factors in affecting hyperglycemia of pregnant woman and future fetal metabolism. Pharmacological and non-pharmacological treatment of gestational diabetes are aimed to maintain euglycemia with regular glucose monitoring, dietary modifications, life style changes, exercise program, and appropriate pharmacotherapy.

Therefore, the aims of this book would be to clarify recent advances in epidemiology, pathophysiology, diagnosis, treatment and medical consequences of gestational diabetes mellitus.

Publishing process

Book initiated and editor appointed

Date completed: April 20th 2021

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline for chapter proposals: May 18th 2021

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Register for the book

Approved chapters written in full and submitted

Deadline for full chapters: July 17th 2021

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: October 5th 2021

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: December 4th 2021

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Miroslav Radenkovic

Faculty of Medicine, University of Belgrade

Miroslav Radenković, MD, graduated from the Faculty of Medicine – University of Belgrade in 1995, and from 1996 he is working in the Department of Pharmacology, Clinical Pharmacology and Toxicology (Faculty of Medicine – University of Belgrade, Serbia), currently in the position of the full-time professor. He received an MSc, board certified in Clinical Pharmacology, PhD, and sub-specialization in Clinical Pharmacology - Pharmacotherapy in 1999, 2000, 2004, and 2016 respectively, from the Faculty of Medicine – University of Belgrade. Currently, Dr. Radenković is finishing Bioethics Masters Program at the Clarkson University, USA. From 2002 Dr. Radenković officially participates in research activities of several scientific projects supported by the Ministry of Science – Serbia, and recently he became an official participant of the NIH Fogarty International Center Project with the main aim of establishing a bioethics masters program at the Faculty of Medicine in Belgrade. In 2007 he was a senior postdoc and principal investigator of the scientific project financed by the Austrian Science Fund at the Medical University of Vienna, Austria. In 2011 Dr. Radenković acted as a book editor of Gestational Diabetes published by IntechOpen.

View profile

Book chapters authored 1

Books edited 1

Introducing your Author Service Manager

Mrs. Mia Vulovic

As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact.

Ask a question
creativecommons
alpsp
cope
stm
ithenticate
crossref
doi
oaspa

Book will be abstracted and indexed in

googlescholar
worldcat
base
az
openaire